---
layout: minimal-medicine
title: Dabrafenib
---

# Dabrafenib
### Generic Name
Dabrafenib

### Usage

Dabrafenib is a targeted therapy primarily used to treat certain types of cancer with a specific genetic mutation called *BRAF* V600E or V600K.  This mutation is found in several cancers, making Dabrafenib useful in various contexts:

* **Melanoma:** Dabrafenib is a key treatment for unresectable or metastatic melanoma (skin cancer)  that has the *BRAF* V600E or V600K mutation. It can be used as a single agent or in combination with another drug, trametinib.  It's also used adjuvantly (after surgery) in patients with melanoma and lymph node involvement.

* **Non-Small Cell Lung Cancer (NSCLC):**  Dabrafenib, typically in combination with trametinib, treats metastatic NSCLC with the *BRAF* V600E mutation.

* **Anaplastic Thyroid Cancer (ATC):**  For patients with locally advanced or metastatic ATC and the *BRAF* V600E mutation, who lack satisfactory alternative treatments, Dabrafenib (usually with trametinib) offers a treatment option.

* **Other Solid Tumors:** Dabrafenib is indicated, in combination with trametinib, for treating adult and pediatric patients (6 years and older) with unresectable or metastatic solid tumors harboring the *BRAF* V600E mutation. This is typically used in cases where the cancer has progressed after prior treatment and there aren't suitable alternative options.


It's crucial to remember that Dabrafenib is *not* used to treat colorectal cancer due to inherent resistance, nor is it effective against solid tumors without the *BRAF* V600E or V600K mutation.  A confirmed genetic test is always necessary before starting treatment.


### Dosage

Dabrafenib dosage varies depending on the cancer type, patient age (for pediatric use), weight (for pediatric use), and whether it's used alone or with trametinib.  Dosage adjustments are also necessary based on several factors including toxicity and hepatic/renal function. Always consult the prescribing information for the most up-to-date and precise details.  The information below is for general understanding only and should not be used for self-medication:

**Adults:** The typical dose is 150 mg twice daily (BID), approximately every 12 hours.  This is true for melanoma, NSCLC, and ATC treatments, though combinations with trametinib often have specific dosing guidelines.

**Pediatric Patients (≥6 years, ≥26 kg):**  The dose is weight-based and administered in combination with trametinib:

* 26-37 kg: Dabrafenib 75 mg BID
* 38-50 kg: Dabrafenib 100 mg BID
* ≥51 kg: Dabrafenib 150 mg BID

Specific trametinib dosages accompany these Dabrafenib doses, and are weight dependent.

**Dosage Adjustments:** Dosage reductions are often necessary due to side effects.  Specific adjustments are made based on the severity and type of adverse effects.  These adjustments are outlined in detail in the prescribing information and should only be made under the supervision of a healthcare professional.  Hepatic and renal impairment may also require dosage modifications.


### Side Effects

Common side effects (occurring in more than 10% of patients) include:

* Chills
* Headache
* Cough
* Constipation
* Alopecia (hair loss)
* Skin rash (various types)
* Dry skin
* Hyperglycemia (high blood sugar)
* Hyponatremia (low sodium)
* Hypophosphatemia (low phosphate)
* Joint pain (arthralgia)
* Muscle pain (myalgia)
* Fever

Less common but potentially serious side effects include:

* Cardiomyopathy (heart muscle disease)
* Severe skin reactions (Stevens-Johnson syndrome, DRESS)
* Severe febrile reactions
* New primary malignancies (including skin cancers)
* Hemorrhage (bleeding)
* Uveitis (eye inflammation)
* QT prolongation (heart rhythm abnormality)
* Venous thromboembolism (blood clots)


**Always contact your healthcare provider immediately if you experience any concerning side effects.**

### How it Works

Dabrafenib is a BRAF inhibitor.  BRAF is a protein kinase involved in cell growth and division.  Certain mutations in the BRAF gene (like V600E and V600K) lead to uncontrolled cell growth, contributing to cancer development.  Dabrafenib works by selectively blocking the activity of these mutated BRAF proteins, thereby slowing or stopping tumor growth. When used with trametinib, the combined effect further inhibits the MAPK pathway, enhancing the anti-cancer action.


### Precautions

* **Contraindications:** Dabrafenib is contraindicated in patients with hypersensitivity to it or its components.

* **Drug Interactions:** Dabrafenib can interact with other medications, especially those metabolized by the same liver enzymes (CYP3A4 and CYP2C8).  Strong inhibitors or inducers of these enzymes can significantly alter Dabrafenib levels.  Concurrent use with certain other drugs should be avoided or carefully monitored.

* **Pregnancy and Breastfeeding:**  Dabrafenib can harm a developing fetus. Women of childbearing age must use effective contraception during treatment and for two weeks afterward.  Breastfeeding is not recommended during treatment and for two weeks following the final dose.

* **Fertility:** Dabrafenib may impair fertility in both men and women.

* **Specific Populations:** Dosage adjustments may be needed in patients with liver or kidney problems.  Special care is required in older adults and children.

* **Monitoring:** Regular monitoring of blood glucose, electrolytes, and liver and kidney function is necessary.  Skin examinations are essential to detect new skin cancers.



### FAQs

* **Q: How should I store Dabrafenib?** A: Store Dabrafenib at room temperature, away from moisture and light. Refer to the product labeling for precise storage instructions.

* **Q: Can I take Dabrafenib with other medications?** A:  It's crucial to discuss all medications, supplements, and herbal remedies you're taking with your doctor or pharmacist before starting Dabrafenib.  Some interactions can be dangerous.

* **Q: What should I do if I miss a dose?** A: Take the missed dose as soon as you remember, unless it's within 6 hours of your next dose.  Do not double up on doses.

* **Q: How long will I need to take Dabrafenib?** A: The duration of treatment depends on your response to the medication and your cancer type.  Your doctor will determine the appropriate treatment length.

* **Q: What are the long-term effects of Dabrafenib?** A: Long-term effects vary among individuals. Regular check-ups and monitoring are essential to detect and manage potential issues.  Discuss any concerns with your doctor.

**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult your healthcare provider for personalized guidance regarding Dabrafenib or any other medication.
